Stock Information
Haemonetics Corp (HAE)
Ticker Symbol: HAE
Exchange: NYSE
Sector: Health Care
Market Cap: $2,963.99 mil
Piotroski score: 7
PE Ratio: 14.9292
EPS (TTM): 3.6395
Revenue (TTM): $28.06 M
Dividend Yield: N/A%
ROE: 20.26%
Latest News
-
GVS SpA (STU:4YQ) Q4 2025 Earnings Call Highlights: Strong Safety Division Growth Amidst Challenges
Tue, Mar 31, 2026 1:01 AM
-
Haemonetics Receives FDA Approval for Expanded Labeling of the VASCADE MVP® XL Venous Vascular Closure System
Mon, Mar 30, 2026 8:15 PM
-
Haemonetics Receives FDA Approval To Expand Labeling For VASCADE MVP XL Venous Vascular Closure System
Mon, Mar 30, 2026 4:18 PM
Key Financials
Financial data not available
